A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus

INTRODUCTION: The prevalence of obesity and obesity-related diseases, including type 2 diabetes mellitus (T2DM), is increasing. Exclusion of the foregut, as occurs in Roux-en-Y gastric bypass, has a key role in the metabolic improvements that occur following bariatric surgery, which are independent...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaysher, Michael Alan, Mohanaruban, Aruchuna, Prechtl, Christina Gabriele, Goldstone, Anthony P, Miras, Alexander Dimitri, Lord, Joanne, Chhina, Navpreet, Falaschetti, Emanuela, Johnson, Nicholas Andrew, Al-Najim, Werd, Smith, Claire, Li, Jia V, Patel, Mayank, Ahmed, Ahmed R, Moore, Michael, Poulter, Neil, Bloom, Stephen, Darzi, Ara, Le Roux, Carel, Byrne, James P, Teare, Julian P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695522/
https://www.ncbi.nlm.nih.gov/pubmed/29146657
http://dx.doi.org/10.1136/bmjopen-2017-018598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695522/
https://www.ncbi.nlm.nih.gov/pubmed/29146657
http://dx.doi.org/10.1136/bmjopen-2017-018598

Ejemplares similares